Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Plummer

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinics in Chest Medicine|May 28, 2016
Dysglycemia and Glucose Control During SepsisMark P Plummer, Adam M Deane
Current Opinion in Critical Care|March 28, 2026
Glucagon-like peptide-1 drugs, gastrointestinal function and critical illnessAniket Nadkarni, Adam M Deane, Mark P Plummer
Current Opinion in Clinical Nutrition and Metabolic Care|July 5, 2022
Is it time to personalise glucose targets during critical illness?Mark P Plummer, Jeroen Hermanides, Adam M Deane
Critical Care Clinics|February 21, 2019
Incretin Physiology and Pharmacology in the Intensive Care UnitMark P Plummer, Jeroen Hermanides, Adam M Deane
Current Opinion in Critical Care|July 7, 2022
Update on glucose control during and after critical illnessAdam M Deane, Mark P Plummer, Yasmine Ali Abdelhamid
Critical Care (London, England)|July 11, 2013
The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?Mark P Plummer, Juris J Meier, Adam M Deane
Current Opinion in Critical Care|March 12, 2019
Gut dysmotility in the ICU: diagnosis and therapeutic optionsMark P Plummer, Annika Reintam Blaser, Adam M Deane
Chest|October 18, 2020
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysisElinor Tan, Jialu Song, Adam M Deane, et al.
Current Opinion in Critical Care|January 25, 2021
Gut dysfunction in the ICU: diagnosis and managementLee-Anne S Chapple, Mark P Plummer, Marianne J Chapman
Critical Care (London, England)|March 8, 2014
Incretins and the intensivist: what are they and what does an intensivist need to know about them?Mark P Plummer, Marianne J Chapman, Michael Horowitz, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinics in Chest Medicine|May 28, 2016
Dysglycemia and Glucose Control During SepsisMark P Plummer, Adam M Deane
Current Opinion in Critical Care|March 28, 2026
Glucagon-like peptide-1 drugs, gastrointestinal function and critical illnessAniket Nadkarni, Adam M Deane, Mark P Plummer
Current Opinion in Clinical Nutrition and Metabolic Care|July 5, 2022
Is it time to personalise glucose targets during critical illness?Mark P Plummer, Jeroen Hermanides, Adam M Deane
Critical Care Clinics|February 21, 2019
Incretin Physiology and Pharmacology in the Intensive Care UnitMark P Plummer, Jeroen Hermanides, Adam M Deane
Current Opinion in Critical Care|July 7, 2022
Update on glucose control during and after critical illnessAdam M Deane, Mark P Plummer, Yasmine Ali Abdelhamid
Critical Care (London, England)|July 11, 2013
The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?Mark P Plummer, Juris J Meier, Adam M Deane
Current Opinion in Critical Care|March 12, 2019
Gut dysmotility in the ICU: diagnosis and therapeutic optionsMark P Plummer, Annika Reintam Blaser, Adam M Deane
Chest|October 18, 2020
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysisElinor Tan, Jialu Song, Adam M Deane, et al.
Current Opinion in Critical Care|January 25, 2021
Gut dysfunction in the ICU: diagnosis and managementLee-Anne S Chapple, Mark P Plummer, Marianne J Chapman
Critical Care (London, England)|March 8, 2014
Incretins and the intensivist: what are they and what does an intensivist need to know about them?Mark P Plummer, Marianne J Chapman, Michael Horowitz, et al.
Pageof 8